Clinical Trial Update: Perfluorocarbon (PFC) Inhalation Treatment of Acute Lung Injury/Acute Respiratory Distress Syndrome [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update of inhaled perfluorocarbon for adults with acute lung injury and acute respiratory distress syndrome; the current status is unknow…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lung Injury
• Respiratory Distress Syndrome

Drugs mentioned

• Perfluorocarbon inhalation (perfluorocarbon)

Snippet

Sponsor: Chinese PLA General Hospital | Conditions: Respiratory Distress Syndrome, Adult, Acute Lung Injury | Phase 2 | Status: UNKNOWN